The number of new COVID-19 cases per week has nearly doubled globally over the past two months, approaching the highest rate seen so far during the pandemic, the head of the World Health Organisation said on Friday.
At an event organised by the Gavi Vaccine Alliance to boost support for the COVAX vaccine-sharing initiative, the officials appealed for another $2 billion by June for the programme, which aims to buy up to 1.8 billion doses in 2021.
Essential workers, persons in congregate settings, those over 18 with comorbidities are also among those eligible to receive COVID-19 shots in SA’s second phase of its vaccine rollout programme. However for now, government wants to prioritise the registration of the elderly.
The United States is preparing for the possibility that a booster shot will be needed between nine to 12 months after people are initially vaccinated against COVID-19, a White House official said on Thursday.
Brazil’s hospitals were running out of drugs needed to sedate COVID-19 patients on Thursday, with the government urgently seeking to import supplies amid reports of the seriously ill being tied down and intubated without effective sedatives.
Many Africans who have received their first COVID-19 vaccine do not know when they will get a second shot because deliveries are delayed, the continent’s top public health official said on Thursday.
Health Minister Dr Zweli Mkhize is expected to visit Nelson Mandela Bay in the Eastern Cape on Thursday to assess the state of healthcare.
Members of a US health panel on Wednesday voiced concern over resuming vaccinations with Johnson & Johnson’s COVID-19 shot, even as a US Food and Drug Administration scientist said warnings could mitigate the risk of rare but serious blood clots.
Advocacy organization Global Citizen has called on governments, businesses and philanthropists to pledge more funds to help get at least two billion Covid19 vaccine doses for lower-income countries amid the pandemic
Health Minister Dr Zweli Mkhize has told Parliament that Johnson and Johnson is refusing to sign off the supply of a further 20 million doses of the COVID-19 vaccine unless it receives a letter from the Department of Trade and Industry (DTI) endorsing the local investment it has made in Aspen pharmaceuticals.